Nitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop
Mutagenesis · 2026
DOI: 10.1093/mutage/geag011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mutagenesis, 2026. Verfasst von Aisar Atrakchi und 16 weiteren Autor:innen. Beteiligte Einrichtung: US Food and Drug Administration/Center for Drug Evaluation and Research, Silver Spring, MD 20993, United States. Hauptthemen laut MEDLINE: Mutagens, Nitrosamines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Detection of N-nitrosamines (NA) in pharmaceuticals became a point of interest due to the mutagenic and carcinogenic potential of some compounds of this class, and their identification as nitrosated forms of marketed drugs, otherwise known as NA Drug Substance-Related Impurities (NDSRIs). The Ames test is used to assess the mutagenic potential of drug impurities, including NAs. Concerns over the sensitivity of the Ames test, as recommended in Organization for Economic Co-operation and Development Test Guideline 471, in predicting the rodent carcinogenic potential of NAs has prompted optimization of several test parameters used for detecting the mutagenicity of NAs (e.g. methods used for metabolic activation and the selection of tester strains). In order to discuss optimal Ames test conditions for the evaluation of NAs, including NDSRIs, the Office of New Drugs in the US Food and Drug Administration’s Center for Drug Evaluation and Research and the Health and Environmental Sciences Institute’s Genetic Toxicology Technical Committee co-organized and co-sponsored a workshop entitled “Nitrosamines: Ames Data Review and Method Development Workshop”. The workshop featured five sessions addressing charge questions pertinent to the Ames test conditions and performance through the presentation of data and panel discussions. This report outlines the key takeaway points from the workshop.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- US Food and Drug Administration/Center for Drug Evaluation and Research, Silver Spring, MD 20993, United States.
- Health and Environmental Sciences Institute, Washington, DC 20005, United States.
- Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, Foster City, CA 94404, United States.
- Pfizer Research, Development, and Medical, Groton, CT 06370, United States.
- Sanofi, R&D Translational Medicine Preclinical Safety, Frankfurt D-69526, Germany.
- BfArM (Federal Institute for Drugs and Medical Devices), Licensing 2, Unit Pharmaceutical Biotechnology, Genetic and Reproductive Toxicology, Bonn 53175, Germany.
ORCID-Profile: Raechel Puglisi, Joel Bercu, Andreas Czich, Roland Froestchl, Robert H Heflich, Tetyana Kobets, Timothy J McGovern, Anthony Lynch, Maik Schuler, Alisa Vespa, Rhys Whomsley, Connie L Chen
Zitieren
APA
Atrakchi, A., Puglisi, R., Bercu, J., Cheung, J., Czich, A., Froestchl, R., Davis-Bruno, K., Heflich, R. H., Kobets, T., McGovern, T. J., Lynch, A., Selby, M., Schuler, M., Silveira, G. O., Vespa, A., Whomsley, R., & Chen, C. L. (2026). Nitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop. Mutagenesis. https://doi.org/10.1093/mutage/geag011
Vancouver
Atrakchi A, Puglisi R, Bercu J, Cheung J, Czich A, Froestchl R, et al. Nitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop. Mutagenesis. 2026. doi:10.1093/mutage/geag011
BibTeX
@article{Atrakchi2026,
author = {Atrakchi, Aisar and Puglisi, Raechel and Bercu, Joel and Cheung, Jennifer and Czich, Andreas and Froestchl, Roland and Davis-Bruno, Karen and Heflich, Robert H and Kobets, Tetyana and McGovern, Timothy J and Lynch, Anthony and Selby, Max and Schuler, Maik and Silveira, Gabriela De Oliveira and Vespa, Alisa and Whomsley, Rhys and Chen, Connie L},
title = {Nitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop},
journal = {Mutagenesis},
year = {2026},
doi = {10.1093/mutage/geag011}
}
EUVIMED